Using molecular techniques, researchers improved diagnosis and treatment of cancer

May 13, 2014
Using molecular techniques, researchers improved diagnosis and treatment of cancer

The ABC Medical Center, located in Mexico City, implemented various molecular diagnostic methods that can detect the genetic alterations in several types of cancer, so they can select a personalized therapy for each patient and direct it against the mutated genes that cause disease.

For this the Laboratory of Molecular Pathology was created, thanks to a who decided to make a donation to the hospital to acquire the necessary equipment, sensitive to the existing need in Mexico for a place where timely diagnosis of the disease is made.

"While the techniques of have been applied to clinical diagnosis for over 20 years, they had just been established in the country. It is estimated that only about five years ago in some of the National Institutes of Health and universities, where it was first used in the field of research, "says Dr. César Lara Torres, head of the laboratory.

Before, when required, samples of tumor tissue were sent to laboratories located abroad to have them analyzed by molecular techniques, making management difficult and increasing diagnosis time and costs.

The researcher also explains that the tools of molecular biology allow to find alterations in the genetic information contained in deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) associated with mutations linked to certain cancers and molecular targets, for which a drug that works more effectively has been found.

"There are several examples of the above, as is the case of chronic granulocytic leukemia, a type of cancer that arises inside bone marrow and leads to rapid growth of immature cells that produce a certain type of white blood cells. This disease is caused due to a reciprocal translocation (displacement of a segment of a chromosome to a new location in the genome) of chromosomes 9 and 22, wherein there is overexpression of a protein (tyrosine kinase) that may be inhibited by a drug called imatinib," explains Lara Torres.

According to the pathologist, this diagnosis is useful for a significant percentage of the different , since there are tumors in which a large amount of specific molecular markers or mutations are located. However, he recognizes that there are cases where it is unknown what happens genetically within the tumor.

"Of the more common tumors where it is possible to detect a large number of are breast, colon, ovarian, lung and blood, among others, so the molecular diagnosis allows to predict their behavior," he says.

He also indicates that molecular biology techniques which are mostly used for their simplicity, affordable costs and ease of implementation are called fluorescent in situ hybridization (FISH) , PCR , real time PCR , endpoint PCR and sequencing, which are all used in the Laboratory of Molecular Pathology of the ABC Hospital.

Regarding their functioning, Dr. Lara Torres says that they are focused on identifying alterations in DNA and RNA. And as for its benefits, he highlights that they increase sensitivity and specificity in the diagnosis of diseases. "They are not a substitute for traditional studies, but a complement, for example, for physical, clinical, imaging and histology (tissue sample analysis under a microscope) examination."

With the implementation of molecular diagnostic techniques in the ABC Hospital it has been possible to reduce waiting times form four weeks to a few days. This helps the oncologist define a patient's treatment faster, improving the prognosis of the disease.

Explore further: Scientists identify genetic blueprint for cancerous tumors of the appendix

Related Stories

Scientists identify genetic blueprint for cancerous tumors of the appendix

May 12, 2014
Using next generation DNA sequencing, Dartmouth scientists have identified potentially actionable mutations in cancers of the appendix. Their study, "Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel ...

Team issues state-of-the-state on genetic-based testing and treatment for breast cancer

March 24, 2014
Dartmouth researchers at its Norris Cotton Cancer Center have compiled a review of the role that information gathered through genetic testing plays in the diagnosis and treatment of breast cancer. The paper entitled "Personalized ...

Molecular tumor board helps in advanced cancer cases

May 5, 2014
With accelerating development of personalized cancer treatments matched to a patient's DNA sequencing, proponents say frontline physicians increasingly need help to maneuver through the complex genomic landscape to find the ...

Mayo Clinic launches 50-gene cancer panel test

April 28, 2014
Mayo Clinic announces the launch of CANCP, a new gene panel cancer test to help tailor chemotherapy to the individual patient based on the unique genomic signature of the patient's tumor. CANCP, an abbreviation for Solid ...

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

May 11, 2012
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular ...

New approach to leukemia testing may better define prognosis, treatment

March 29, 2014
Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.